[Alternative treatment to interferon therapy in chronic viral hepatitis].
Salmerón Escobar
F J
FJ
Servicio de Digestivo, Hospital Universitario de Granada.
D000111:Acetylcysteine / Q000627:therapeutic use; D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D016375:Antisense Elements (Genetics) / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D002756:Cholagogues and Choleretics / Q000627:therapeutic use; D006509:Hepatitis B / Q000188:drug therapy*; D006526:Hepatitis C / Q000188:drug therapy*; D006521:Hepatitis, Chronic / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007369:Interferon Inducers / Q000627:therapeutic use; D011063:Poly A-U / Q000627:therapeutic use; D016337:RNA, Catalytic / Q000627:therapeutic use; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D016375:Antisense Elements (Genetics); D000998:Antiviral Agents; D002756:Cholagogues and Choleretics; D007166:Immunosuppressive Agents; D007369:Interferon Inducers; D016337:RNA, Catalytic; D011063:Poly A-U; D014580:Ursodeoxycholic Acid; D000111:Acetylcysteine
Tratamiento alternativo al interferón en la hepatitis crónica viral.